摘要
Background: Machine learning (ML) prediction models to support clinical management of blood-borne viral infections are becoming increasingly abundant in medical literature, with a number of competing models being developed for the same outcome or target population. However, evidence on the quality of these ML prediction models are limited.Objective: This study aimed to evaluate the development and quality of reporting of ML prediction models that could facilitate timely clinical management of blood-borne viral infections. Methods: We conducted narrative evidence synthesis following the synthesis without meta-analysis guidelines. We searched PubMed and Cochrane Central Register of Controlled Trials for all studies applying ML models for predicting clinical outcomes associated with hepatitis B virus (HBV), human immunodeficiency virus (HIV), or hepatitis C virus (HCV).Results: We found 33 unique ML prediction models aiming to support clinical decision making. Overall, 12 (36.4%) focused on HBV, 10 (30.3%) on HCV, 10 on HIV (30.3%) and two (6.1%) on co-infection. Among these, six (18.2%) addressed the diagnosis of infection, 16 (48.5%) the prognosis of infection, eight (24.2%) the prediction of treatment response, two (6.1%) progression through a cascade of care, and one (3.03%) focused on the choice of antiretroviral therapy (ART). Nineteen prediction models (57.6%) were developed using data from high-income countries. Evaluation of prediction models was limited to measures of performance. Detailed information on software code accessibility was often missing. Independent validation on new datasets and/or in other institutions was rarely done.Conclusion: Promising approaches for ML prediction models in blood-borne viral infections were identified, but the lack of robust validation, interpretability/explainability, and poor quality of reporting hampered their clinical relevance. Our findings highlight important considerations that can inform standard reporting guidelines for ML prediction models in the future (e.g., TRIPOD-AI), and provides critical data to inform robust evaluation of the models.
学科与关键词
- Machine learning for clinical decision support in infectious diseases: a narrative review of current applicationsPeiffer-Smadja, N.*; Rawson, T. M.; Ahmad, R.; Buchard, A.; Pantelis, G.; Lescure, F-X; Birgand, G.; Holmes, A. H.CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26(5): 584-595.被引 245
- Utilizing machine learning-based predictive models to identify early virological recurrence in Chinese chronic hepatitis B patients following entecavir withdrawalLi, Xiaoke; Qiu, Mei; Huang, Yi; Xiao, Huanming; Chen, Hening; Lu, Bingjiu; Jiang, Yuyong; Long, Fuli; Lin, Hui; He, Jinyu; Zhang, Mingxiang; Wu, Qikai; Wang, Li; Zhu, Xiaoning; Gong, Man; Sun, Jianguang; Sun, Xuehua; Sun, Fengxia; Lu, Wei; Xu, Weihua; Du, Hongbo; Ye, Yong'an
- Intelligent diagnosis system of hepatitis C virus: A probabilistic neural network based approachTerlapu, Panduranga Vital*; Gedela, Stalin Babu; Gangu, Vijay Kumar; Pemula, RambabuINTERNATIONAL JOURNAL OF IMAGING SYSTEMS AND TECHNOLOGY, 2022, 32(6): 2107-2136.被引 3
